Toxoplasmosis and allogeneic stem cell transplantation: can we do better?
Slavin
Monica A
MA
Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. monica.slavin@petermac.org
D019337:Hematologic Neoplasms / Q000469:parasitology* / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D015996:Survival Rate; D014122:Toxoplasma / Q000472:pathogenicity*; D014123:Toxoplasmosis / Q000175:diagnosis*; D014184:Transplantation, Homologous; D016896:Treatment Outcome